Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

SC Palmer, SD Navaneethan, JC Craig… - Annals of internal …, 2010 - acpjournals.org
Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating
agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional …
被引用次数：474 相关文章

Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease

SC Palmer, SD Navaneethan… - Annals of Internal …, 2010 - researchnow.flinders.edu.au
Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating
agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional …
[PDF] academia.edu

[PDF][PDF] Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

SC Palmer, SD Navaneethan, JC Craig, DW Johnson… - 2019 - academia.edu
This review assessed the effects of erythropoiesis-stimulating agents on anaemia in patients
with chronic kidney disease and concluded that higher haemoglobin target levels increased …

[引用][C] Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

SC PALMER, SD NAVANEETHAN… - Annals of internal …, 2010 - pascal-francis.inist.fr
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

SC Palmer, SD Navaneethan, JC Craig… - Annals of Internal …, 2010 - europepmc.org
Background Previous meta-analyses suggest that treatment with erythropoiesis-stimulating
agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional …

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

SC Palmer, SD Navaneethan… - Annals of internal …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Previous meta-analyses suggest that treatment with erythropoiesis-stimulating
agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional …
[HTML] nih.gov

[HTML][HTML] Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease

SC Palmer, SD Navaneethan, JC Craig… - Database of Abstracts …, 2010 - ncbi.nlm.nih.gov
This review assessed the effects of erythropoiesis-stimulating agents on anaemia in patients
with chronic kidney disease and concluded that higher haemoglobin target levels increased …

[引用][C] Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease

SC Palmer, SD Navaneethan… - Annals of Internal …, 2010 - espace.library.uq.edu.au
Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating
agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional …

[引用][C] Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

S Palmer, S Navaneethan, J Craig… - ANNALS OF …, 2010 - ricerca.uniba.it
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …

[引用][C] Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

SC Palmer - Annals of Internal Medicine, 2010 - cir.nii.ac.jp
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …